Shanghai Allist Pharmaceuticals Hits Day High with 11.09% Surge

Shanghai Allist Pharmaceuticals Co., Ltd. has experienced significant activity today, marking a notable gain of 11.09% as of July 20, 2026. The stock reached an intraday high of CNY 129.95, reflecting strong performance metrics that distinguish it within the pharmaceuticals and biotechnology sector. In terms of performance, Shanghai Allist has outpaced the China Shanghai Composite index, which recorded a modest increase of 0.85% for the day. Over the past week, the stock has risen by 8.34%, while its one-month performance shows an impressive increase of 49.91%. Year-to-date, the stock has gained 22.34%, significantly outperforming the composite index, which has declined by 4.35%. The company has consistently reported positive results, with operating cash flow reaching a peak of CNY 2,163.79 million and a net profit of CNY 1,187.76 million, reflecting a robust growth rate of 59.72%. With a return on equity of 30.78% and a price-to-book ratio of 4.67, Shanghai Allist Pharmaceuticals continues to demonstrate strong financial health and market positioning.